- Home
- Publications
- Publication Search
- Publication Details
Title
NRF2 Enables EGFR Signaling in Melanoma Cells
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 8, Pages 3803
Publisher
MDPI AG
Online
2021-04-07
DOI
10.3390/ijms22083803
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity
- (2021) Yann Cheli et al. Molecular Cancer
- MITF reprograms the extracellular matrix and focal adhesion in melanoma
- (2021) Ramile Dilshat et al. eLife
- Cancer cells escape autophagy inhibition via NRF2-induced macropinocytosis
- (2021) Hua Su et al. CANCER CELL
- CRISPR screens identify tumor‐promoting genes conferring melanoma cell plasticity and resistance
- (2021) Arthur Gautron et al. EMBO Molecular Medicine
- NRF2 Activates Growth Factor Genes and Downstream AKT Signaling to Induce Mouse and Human Hepatomegaly
- (2020) Feng He et al. JOURNAL OF HEPATOLOGY
- NRF2 as a regulator of cell metabolism and inflammation in cancer
- (2020) Feng He et al. CARCINOGENESIS
- Lymph protects metastasizing melanoma cells from ferroptosis
- (2020) Jessalyn M. Ubellacker et al. NATURE
- The transcription factor NRF2 enhances melanoma malignancy by blocking differentiation and inducing COX2 expression
- (2020) Christina Jessen et al. ONCOGENE
- NRF2‐dependent stress defense in tumor antioxidant control and immune evasion
- (2020) José Pedro Friedmann Angeli et al. Pigment Cell & Melanoma Research
- Loss of ACK1 Upregulates EGFR and Mediates Resistance to BRAF Inhibition
- (2020) Zhenyu Ji et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The Oncogenic Action of NRF2 Depends on De-glycation by Fructosamine-3-Kinase
- (2019) Viraj R. Sanghvi et al. CELL
- JASPAR 2020: update of the open-access database of transcription factor binding profiles
- (2019) Oriol Fornes et al. NUCLEIC ACIDS RESEARCH
- Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress
- (2018) Jennifer Tsoi et al. CANCER CELL
- Antioxidant response elements: Discovery, classes, regulation and potential applications
- (2018) Azhwar Raghunath et al. Redox Biology
- Oxidative Stress and Antioxidants in the Pathophysiology of Malignant Melanoma
- (2018) Elena Obrador et al. BIOLOGICAL CHEMISTRY
- The identification of patient-specific mutations reveals dual pathway activation in most patients with melanoma and activated receptor tyrosine kinases in BRAF/NRAS wild-type melanomas
- (2018) Silke Appenzeller et al. CANCER
- NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer
- (2016) Iok In Christine Chio et al. CELL
- The transcription factor RUNX2 regulates receptor tyrosine kinase expression in melanoma
- (2016) Rajeev K. Boregowda et al. Oncotarget
- Tunable-Combinatorial Mechanisms of Acquired Resistance Limit the Efficacy of BRAF/MEK Cotargeting but Result in Melanoma Drug Addiction
- (2015) Gatien Moriceau et al. CANCER CELL
- Genomic Classification of Cutaneous Melanoma
- (2015) Rehan Akbani et al. CELL
- Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer
- (2015) Scott Kopetz et al. JOURNAL OF CLINICAL ONCOLOGY
- MITF Modulates Therapeutic Resistance through EGFR Signaling
- (2015) Zhenyu Ji et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state
- (2015) Annelien Verfaillie et al. Nature Communications
- The MAPK pathway as an apoptosis enhancer in melanoma
- (2015) Johannes M. Haydn et al. Oncotarget
- Comprehensive molecular profiling of lung adenocarcinoma
- (2014) Eric A. Collisson et al. NATURE
- Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma
- (2014) Chong Sun et al. NATURE
- Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma
- (2014) Georgina V. Long et al. Nature Communications
- Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma
- (2014) Judith Müller et al. Nature Communications
- A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway Inhibitors
- (2014) D. J. Konieczkowski et al. Cancer Discovery
- Oxidative stress in melanocyte senescence and melanoma transformation
- (2013) Svenja Meierjohann EUROPEAN JOURNAL OF CELL BIOLOGY
- Tumor angiogenesis is caused by single melanoma cells in a manner dependent on reactive oxygen species and NF- B
- (2013) M. K. Schaafhausen et al. JOURNAL OF CELL SCIENCE
- Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy
- (2013) H. Shi et al. Cancer Discovery
- MAP Kinase Pathway Alterations in BRAF-Mutant Melanoma Patients with Acquired Resistance to Combined RAF/MEK Inhibition
- (2013) N. Wagle et al. Cancer Discovery
- The Genetic Landscape of Clinical Resistance to RAF Inhibition in Metastatic Melanoma
- (2013) E. M. Van Allen et al. Cancer Discovery
- Concurrent MEK2 Mutation and BRAF Amplification Confer Resistance to BRAF and MEK Inhibitors in Melanoma
- (2013) Jessie Villanueva et al. Cell Reports
- Relief of Profound Feedback Inhibition of Mitogenic Signaling by RAF Inhibitors Attenuates Their Activity in BRAFV600E Melanomas
- (2012) Piro Lito et al. CANCER CELL
- Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
- (2012) Anirudh Prahallad et al. NATURE
- Hyperactivation of constitutively dimerized oncogenic EGF receptors by autocrine loops
- (2012) J A G C Laisney et al. ONCOGENE
- EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib
- (2012) Ryan B. Corcoran et al. Cancer Discovery
- Gene expression analysis after receptor tyrosine kinase activation reveals new potential melanoma proteins
- (2010) Janka Teutschbein et al. BMC CANCER
- MMP13 mediates cell cycle progression in melanocytes and melanoma cells: in vitro studies of migration and proliferation
- (2010) Svenja Meierjohann et al. Molecular Cancer
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
- (2010) Ramin Nazarian et al. NATURE
- The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1
- (2010) Masaaki Komatsu et al. NATURE CELL BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started